Vitro Biopharma

14 articles about Vitro Biopharma

• Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat Pitt Hopkins Syndrome, a rare form of Autism

  11/17/2021

  Vitro Biopharma, Inc. announced receipt of FDA authorization and clearance to enroll patients in its IND for a phase I-II, randomized, double-blind, placebo-controlled study of the safety and efficacy of therapeutic treatment with AlloRx Stem Cells® in children with Pitt Hopkins Syndrome, a rare neurogenetic disorder that features autistic traits.

• Vitro Biopharma Inc. July 31st 2021; 3rd Quarter ended Financial Results of Operations and Shareholder Letter.

  10/10/2021

  Vitro Biopharma, Inc. dba Vitro Biopharma, announced its 3rd quarter, ended July 31st 2021, financial results of operations.

• Vitro Biopharma Acquires Fitore Nutrition and Infinivive MD, Adding Revenues from Innovative Stem Cell Activation Products and Topical Cosmetic Stem Cell Serums.

  8/31/2021

  Vitro Biopharma, Inc. announced the acquisition of Fitore Nutrition and Infinivive MD. Fitore, a private company headquartered in Denver, Colorado creates clinically validated supplements and sells them direct to consumers via their unique digital marketing platform and SEO expertise.

• Vitro Biopharma Signs Multi-Million Dollar Operating Service Contract with European Wellness Biomedical Group.

  8/19/2021

  Vitro Biopharma, Inc. announced the signing of a contract with European Wellness Biomedical Group headquartered in Kuala Lumpur, Malaysia and it's start-up subsidiary BioPep being registered in Delaware, USA to develop FDA-approval of biological products derived from existing mitochondrial peptide extracts

• Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter

  4/27/2021

  Vitro Biopharma recorded quarter ended January 31st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic.

• Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director

  4/3/2021

  Vitro Biopharma, Inc. announced the appointment of Dr. Caroline Mosessian, PhD, DRSc, FACMPE, ACHE as its acting Director of Regulatory Affairs.

• Frost & Sullivan Honors Vitro Biopharma For Its Outstanding Technological Innovations And Business Strategy In The Stem Cell Tools Industry

  8/5/2014

• Vitro Biopharma Launches New Stem Cell Products to Accelerate Bone Growth

  1/22/2013

• Vitro Biopharma Launches Products for Drug Development & Advancement of Joint Regeneration Technology

  10/9/2012

• Vitro Biopharma Signs Agreement With StemGenesis for Distribution of Its Stem Cell Products in China

  9/12/2012

• Vitro Biopharma Advances Commercialization of Its Fertility Drugs: Licensing Partner to Seek Registration in International Markets

  8/28/2012

• Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics, Inc.

  7/24/2012

• Vitro Biopharma Launches New Website

  5/9/2012

• Vitro Biopharma Responds to Recent Market Activity

  5/1/2012